{
    "paper_id": "PMC7102609",
    "metadata": {
        "title": "Working through the COVID-19 outbreak: Rapid review and recommendations for MSK and allied heath personnel",
        "authors": [
            {
                "first": "Aparna",
                "middle": [],
                "last": "Viswanath",
                "suffix": "",
                "email": "aviswanath@doctors.org.uk",
                "affiliation": {}
            },
            {
                "first": "Puneet",
                "middle": [],
                "last": "Monga",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "The coronavirus disease 2019 (COVID-19) pandemic presents a significant challenge to the medical profession. The widespread effect of this pandemic and its influence on the practice of orthopaedic surgery and musculoskeletal work is the subject of this work. We discuss the issues revolving personal protection of musculoskeletal (MSK) healthcare workers, non-operative management of musculoskeletal conditions, remote consultations, trauma escalation stages, staff wellbeing and orthopaedic surgery for COVID-19 cases.",
            "cite_spans": [],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "Aerosol (droplets from the patient\u2019s mouth or nose) spread from an infected patient to the health worker via a direct aerosol assault can vary in quantum from low level contamination \u2013 from encounters such as talking \u2013 to high level contamination \u2013 via coughing or sneezing. Such aerosol entry may be via the nose, mouth or eyes of the recipient. The distance of the source to the recipient influences the quantum. A safe distance of 6 feet is recommended when possible to minimize such aerosol spread during clinical encounters.1\n",
            "cite_spans": [
                {
                    "start": 529,
                    "end": 530,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                }
            ],
            "section": "Aerosol spread ::: Understanding the mode of spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ::: Personal protection of MSK and allied health professionals",
            "ref_spans": []
        },
        {
            "text": "SARS-CoV-2 is detectable in aerosols for up to three hours2 and hence aerated rooms are safer than closed spaces. Regular ventilation of closed spaces is advisable.",
            "cite_spans": [
                {
                    "start": 58,
                    "end": 59,
                    "mention": "2",
                    "ref_id": "BIBREF11"
                }
            ],
            "section": "Aerosol spread ::: Understanding the mode of spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ::: Personal protection of MSK and allied health professionals",
            "ref_spans": []
        },
        {
            "text": "A wide variety of aerosol filters (face masks) are available and sometimes the nomenclature can be challenging to understand.2 The two main variables one needs to consider when one decides to choose such a mask is the filter efficiency and whether it provides an airtight fit around the personnel\u2019s mouth and nose. Filter efficiency is tested by assessing the proportion of a 300 nm (0.3 \u03bcm) aerosol challenge, which is filtered by the device. To understand the nomenclature mentioned in the following table, for example, a FFP2 filter will prevent at least 94% of the aerosol challenge from passing through. The European ratings are covered with two standards and the filters are classified as Filtering Face Piece (FFP) [FFP1, FFP2 or FFP3] or P1/P2/P32 \u2013 see Table 1\n.",
            "cite_spans": [
                {
                    "start": 125,
                    "end": 126,
                    "mention": "2",
                    "ref_id": "BIBREF11"
                }
            ],
            "section": "Aerosol spread ::: Understanding the mode of spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ::: Personal protection of MSK and allied health professionals",
            "ref_spans": [
                {
                    "start": 762,
                    "end": 769,
                    "mention": "Table 1",
                    "ref_id": "TABREF0"
                }
            ]
        },
        {
            "text": "The US healthcare lead by Centre for Disease Control (CDC) uses a different nomenclature, although the principle of testing is similar. For example, a N95 mask filters out 95% of particles sized 300 nm3, see Table 2\n.",
            "cite_spans": [],
            "section": "Aerosol spread ::: Understanding the mode of spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ::: Personal protection of MSK and allied health professionals",
            "ref_spans": [
                {
                    "start": 208,
                    "end": 215,
                    "mention": "Table 2",
                    "ref_id": "TABREF1"
                }
            ]
        },
        {
            "text": "The size of coronavirus is around 100 nm (0.1 \u03bcm)4 and hence simple mathematics would suggest that these particles would pass through most of these filters, which are tested for a 300 nm particle challenge. However, particles smaller than 300 nm do not travel in a linear motion; they travel using a zig-zag movement as they are bounced randomly by molecules of comprising air (Brownian motion).2 Hence these particles are often trapped in filters with mesh sizes bigger than themselves. N95 masks are recommended for medium risk clinical encounters. For high-risk encounters, positive pressure suits are recommended.2\n,\n5\n",
            "cite_spans": [
                {
                    "start": 49,
                    "end": 50,
                    "mention": "4",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 395,
                    "end": 396,
                    "mention": "2",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 617,
                    "end": 618,
                    "mention": "2",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 621,
                    "end": 622,
                    "mention": "5",
                    "ref_id": "BIBREF18"
                }
            ],
            "section": "Aerosol spread ::: Understanding the mode of spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ::: Personal protection of MSK and allied health professionals",
            "ref_spans": []
        },
        {
            "text": "Many of the re-useable commercially available Facemasks (respirators) for protection during spray painting/woodwork/industrial fumes are FFP3/P3 category and would offer protection against a heavy viral aerosol challenge. However, most of these are not easy to sterilize and neither licensed for medical use. There is a risk of the virus staying alive on the respirator surface (up to 3 days on plastic)6 and hence their repeated use cannot be recommended in the context of the COVID-19 pandemic. It may be too expensive for these to be used on a disposable basis (approximately \u00a3100 cost per piece), but in case of dire shortage of supplies, and if they can be mass-produced in the country, they will have a potential role in clinical encounters such as the subject of this document.",
            "cite_spans": [
                {
                    "start": 403,
                    "end": 404,
                    "mention": "6",
                    "ref_id": "BIBREF19"
                }
            ],
            "section": "Aerosol spread ::: Understanding the mode of spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ::: Personal protection of MSK and allied health professionals",
            "ref_spans": []
        },
        {
            "text": "Surgical face masks are not designed for personnel protection and do not closely fit around the face and mouth. Their design is intended for preventing contamination of the surgical wound from the aerosols generating by the surgical team. When tested for personal protection, in lab settings, they provide a 35% protection against a standard lab aerosol challenge.3 There are no clinical studies comparing N95/P2 masks to surgical masks for prevention against coronavirus but studies have compared these two masks in the setting of influenza virus (which is a similar sized virus and is also airborne).7 Despite the differences we have seen in the lab settings, there seem to be no difference in infection rates between these two groups in the clinical setting (2 randomised trials). It is apparent that in the lab setting N95/P2 masks are superior but in the clinical setting such a difference is not seen.",
            "cite_spans": [
                {
                    "start": 364,
                    "end": 365,
                    "mention": "3",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 602,
                    "end": 603,
                    "mention": "7",
                    "ref_id": "BIBREF20"
                }
            ],
            "section": "Aerosol spread ::: Understanding the mode of spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ::: Personal protection of MSK and allied health professionals",
            "ref_spans": []
        },
        {
            "text": "Also, there is evidence to suggest that wearing a mask (either surgical mask or N95) reduces the risks of acquiring the \u2018flu by the close contacts of patients when compared to no protection (3 arm randomised trial),8 Medical Research Council (Imperial College) suggests the use of masks can reduce the chances of developing disease, but notes that the compliance may be poor.7\n",
            "cite_spans": [
                {
                    "start": 215,
                    "end": 216,
                    "mention": "8",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 375,
                    "end": 376,
                    "mention": "7",
                    "ref_id": "BIBREF20"
                }
            ],
            "section": "Aerosol spread ::: Understanding the mode of spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ::: Personal protection of MSK and allied health professionals",
            "ref_spans": []
        },
        {
            "text": "In light of the above evidence, it can be inferred that the surgical masks are not a reliable protection against a known/suspected COVID-19 patient, but they are useful to prevent the personnel against an accidental aerosol challenge from an asymptomatic carrier of SARS-CoV-2 during the incubation phase. Equally if a health worker is in the asymptomatic incubation phase, this will reduce the aerosol challenge towards an uninfected patient or coworker.5\n,\n7 By reducing the viral load acquired, such facemasks are protective for personnel as they are likely to reduce the severity of illness, especially at the height of the pandemic.",
            "cite_spans": [
                {
                    "start": 455,
                    "end": 456,
                    "mention": "5",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 459,
                    "end": 460,
                    "mention": "7",
                    "ref_id": "BIBREF20"
                }
            ],
            "section": "Aerosol spread ::: Understanding the mode of spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ::: Personal protection of MSK and allied health professionals",
            "ref_spans": []
        },
        {
            "text": "It is recommended that a known patient of COVID-19 wears such a mask to reduce viral shedding and hence this measure is protective to the health workers. These masks are also useful for symptomatic patients in self-quarantine to reduce viral load transmission to the rest of the members of family in quarantine.",
            "cite_spans": [],
            "section": "Aerosol spread ::: Understanding the mode of spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ::: Personal protection of MSK and allied health professionals",
            "ref_spans": []
        },
        {
            "text": "Aerosols/droplet contamination via the eye can be prevented by routine use of glasses or visors.6 Such protection would be useful when a direct aerosol challenge may occur such as clinic appointments, reception staff, clinical examination, physiotherapy, phlebotomy, radiology procedures etc.",
            "cite_spans": [
                {
                    "start": 96,
                    "end": 97,
                    "mention": "6",
                    "ref_id": "BIBREF19"
                }
            ],
            "section": "Aerosol spread ::: Understanding the mode of spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ::: Personal protection of MSK and allied health professionals",
            "ref_spans": []
        },
        {
            "text": "Direct contact with contaminated surfaces may also lead to inoculation, for example when the health worker examines the patient and then uses the contaminated hand to rub one\u2019s eye or touch their face. SARS-CoV-2 is detectable for up to 4 h on copper, up to 24 h on cardboard and up to two to three days on plastic and stainless steel.6\n",
            "cite_spans": [
                {
                    "start": 335,
                    "end": 336,
                    "mention": "6",
                    "ref_id": "BIBREF19"
                }
            ],
            "section": "Direct contamination ::: Understanding the mode of spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ::: Personal protection of MSK and allied health professionals",
            "ref_spans": []
        },
        {
            "text": "Hence hand washing with soap and water or disinfecting gel is advisable before and after every patient contact. A direct decontamination of all patient contact points is vital (chairs, door knobs, pens, clipboards etc.) many times each day. It is advisable to avoid touching one\u2019s eyes nose or mouth. It is advisable to cough or sneeze in a tissue and bin the tissue immediately. If tissue is not immediately available, it is best to cough and sneeze into the elbow.9\n",
            "cite_spans": [
                {
                    "start": 466,
                    "end": 467,
                    "mention": "9",
                    "ref_id": "BIBREF22"
                }
            ],
            "section": "Direct contamination ::: Understanding the mode of spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ::: Personal protection of MSK and allied health professionals",
            "ref_spans": []
        },
        {
            "text": "The hospital should be divided into areas affiliated with a level of risk.10\n",
            "cite_spans": [
                {
                    "start": 74,
                    "end": 76,
                    "mention": "10",
                    "ref_id": "BIBREF1"
                }
            ],
            "section": "What should we be wearing? ::: Recommendations ::: Personal protection of MSK and allied health professionals",
            "ref_spans": []
        },
        {
            "text": "Level 1 \u2013 Applicable to pre-exam triage and general outpatient dept.Disposable surgical cap and maskWork uniformDisposable gloves and protective clothing\n",
            "cite_spans": [],
            "section": "What should we be wearing? ::: Recommendations ::: Personal protection of MSK and allied health professionals",
            "ref_spans": []
        },
        {
            "text": "Level 2 \u2013 Applicable to A&E, isolation wards, fever clinics, ICU, specimen examination of suspected or confirmed cases, cleaning surgical instruments.As above ANDMedical protective mask (N95)Goggles\n",
            "cite_spans": [],
            "section": "What should we be wearing? ::: Recommendations ::: Personal protection of MSK and allied health professionals",
            "ref_spans": []
        },
        {
            "text": "Level 3 \u2013 Applicable to surgical theatres on suspected or confirmed cases, intubation, tracheotomy, bronchoscopy, endoscopy, procedures with splash/spray secretions.As above ANDFull face respiratory protective devices or powdered air-purifying respirator\n",
            "cite_spans": [],
            "section": "What should we be wearing? ::: Recommendations ::: Personal protection of MSK and allied health professionals",
            "ref_spans": []
        },
        {
            "text": "Although surgical hoods (such as those made by Stryker) meet AAMI Level 4 personal protection, there has been no study looking at their effectiveness in COVID-19, and as such their use cannot be recommended.",
            "cite_spans": [],
            "section": "What should we be wearing? ::: Recommendations ::: Personal protection of MSK and allied health professionals",
            "ref_spans": []
        },
        {
            "text": "Minimize aerosol related spread:-A safe distance of 6 feet is recommended during clinical encounters-Surgical masks are recommended during all clinical encounters with asymptomatic patients. Surgical masks are recommended for personnel working in areas where air exchange is < 3 h-N95 masks/positive pressure suits are recommended for medium/high risk clinical encounters.-Eye protection is recommended for all clinical encounters.\n",
            "cite_spans": [],
            "section": "What should we be wearing? ::: Recommendations ::: Personal protection of MSK and allied health professionals",
            "ref_spans": []
        },
        {
            "text": "Minimize direct contamination-Hand washing with soap and water or disinfecting gel is advisable before and after every patient contact.-A direct decontamination of all patient/staff contact points is vital (chairs, door knobs, pens, clipboards, keyboard, mouse etc) many times during the working day.-It is advisable to avoid touching one\u2019s eyes, nose or mouth. It is advisable to cough or sneeze in a tissue and bin the tissue immediately. If tissue is not immediately available, it is best to cough and sneeze into the elbow.\n",
            "cite_spans": [],
            "section": "What should we be wearing? ::: Recommendations ::: Personal protection of MSK and allied health professionals",
            "ref_spans": []
        },
        {
            "text": "\n-Minimize personnel entering operating theatre.-Ideally have a negative pressure operating area, a buffer zone and a clean zone.-Put PPE on in the buffer zone; dispose of it in the buffer zone.-Patients should have surgical masks and caps on.\n",
            "cite_spans": [],
            "section": "Operating room procedures ::: Recommendations ::: Personal protection of MSK and allied health professionals",
            "ref_spans": []
        },
        {
            "text": "Ideally divide into teams, with each team only being in a Level 2 or Level 3 area for 4 h at a time.10\n",
            "cite_spans": [
                {
                    "start": 100,
                    "end": 102,
                    "mention": "10",
                    "ref_id": "BIBREF1"
                }
            ],
            "section": "Team working ::: Recommendations ::: Personal protection of MSK and allied health professionals",
            "ref_spans": []
        },
        {
            "text": "The hospital should have a \u2018fever clinic\u2019 running. i.e. anyone who enters A&E or MIU will have their temperature taken. Those with a fever are taken to a \u2018fever clinic\u2019 for further assessment: this is a level 2 zone.",
            "cite_spans": [],
            "section": "Isolation zones ::: Recommendations ::: Personal protection of MSK and allied health professionals",
            "ref_spans": []
        },
        {
            "text": "There is no clear-cut guidance specifically related to staff with comorbidities. However, comorbidities that place individuals at greatest risk are:HypertensionCardiac disease/cerebrovascular diseaseDiabetesRespiratory disease11\nMalignancy and immunodeficiencyThose treated with ACE-inhibitors and ARBs are at greater risk12\n\n",
            "cite_spans": [
                {
                    "start": 226,
                    "end": 228,
                    "mention": "11",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 322,
                    "end": 324,
                    "mention": "12",
                    "ref_id": "BIBREF3"
                }
            ],
            "section": "Staff with comorbidities ::: Recommendations ::: Personal protection of MSK and allied health professionals",
            "ref_spans": []
        },
        {
            "text": "COPD is the most strongly predictive comorbidity for both severe disease and ICU admission13\n",
            "cite_spans": [
                {
                    "start": 90,
                    "end": 92,
                    "mention": "13",
                    "ref_id": "BIBREF4"
                }
            ],
            "section": "Staff with comorbidities ::: Recommendations ::: Personal protection of MSK and allied health professionals",
            "ref_spans": []
        },
        {
            "text": "Methylprednisolone has been linked to prolonged viral shedding14 and WHO advises against their use in COVID-19 except for patients with an associated acute respiratory distress. General corticosteroids have led to delayed viral shedding in MERS-CoV and SARS-CoV, as well as psychosis and avascular necrosis in SARS-CoV and increased mortality in influenza.15\n",
            "cite_spans": [
                {
                    "start": 62,
                    "end": 64,
                    "mention": "14",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 356,
                    "end": 358,
                    "mention": "15",
                    "ref_id": "BIBREF6"
                }
            ],
            "section": "Local steroid injections ::: Non-operative management of MSK disorders during the pandemic outbreak",
            "ref_spans": []
        },
        {
            "text": "In addition, a previous study of over 15,000 cases showed that intra articular steroid administration reduces the efficacy of the influenza vaccine and suggest susceptibility to viral load.16\n",
            "cite_spans": [
                {
                    "start": 189,
                    "end": 191,
                    "mention": "16",
                    "ref_id": "BIBREF7"
                }
            ],
            "section": "Local steroid injections ::: Non-operative management of MSK disorders during the pandemic outbreak",
            "ref_spans": []
        },
        {
            "text": "To date there are no papers specifically looking at intra articular steroid administration in Coronavirus strain COVID-19, but the advice from WHO regarding steroids is to avoid them unless the patient is in ARDS.17\n",
            "cite_spans": [
                {
                    "start": 213,
                    "end": 215,
                    "mention": "17",
                    "ref_id": "BIBREF8"
                }
            ],
            "section": "Local steroid injections ::: Non-operative management of MSK disorders during the pandemic outbreak",
            "ref_spans": []
        },
        {
            "text": "The current advice is not to take NSAIDs in COVID-19 and to use paracetamol to treat symptoms.18 There is speculation that the drug causes \u201ccytokine storms\u201d. Taking the drug in the early stages of the disease may induce prolonged illness or more severe respiratory or cardiac complications.",
            "cite_spans": [
                {
                    "start": 94,
                    "end": 96,
                    "mention": "18",
                    "ref_id": "BIBREF9"
                }
            ],
            "section": "Using NSAIDs medications ::: Non-operative management of MSK disorders during the pandemic outbreak",
            "ref_spans": []
        },
        {
            "text": "The effectiveness of virtual fracture clinics in the UK is now well-established.19, 20, 21 The same research has not been done for elective orthopaedics. Certainly from a follow-up perspective, the virtual clinic is encouraged from the Royal College of Surgeons.22 Many countries across Europe are now conducting telephone outpatient clinics in light of COVID-19.",
            "cite_spans": [
                {
                    "start": 80,
                    "end": 82,
                    "mention": "19",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 84,
                    "end": 86,
                    "mention": "20",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 88,
                    "end": 90,
                    "mention": "21",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 262,
                    "end": 264,
                    "mention": "22",
                    "ref_id": "BIBREF14"
                }
            ],
            "section": "Remote consultations",
            "ref_spans": []
        },
        {
            "text": "GMC has some guidance on this, but it is limited. They suggest ensuring the patient being assessed has capacity, has a straightforward treatment request and that the clinician has all the necessary patient information to hand.The newest guidance from the British Orthopaedic Association suggests changing all, except the most essential, from face-to-face clinics to virtual or telephone clinics.23\n",
            "cite_spans": [
                {
                    "start": 395,
                    "end": 397,
                    "mention": "23",
                    "ref_id": "BIBREF15"
                }
            ],
            "section": "Remote consultations",
            "ref_spans": []
        },
        {
            "text": "Each hospital will have its own escalation plan, but in the first instance it is desirable for specialist teams to work within their own remit, albeit working in emergency mode. For example, orthopaedic surgeons could staff trauma lists, fracture clinics and minor injuries units to treat the walking wounded. At some point however people will have to work outside their specialist area.",
            "cite_spans": [],
            "section": "Trauma escalation plan",
            "ref_spans": []
        },
        {
            "text": "There are studies emerging about the effects of this rapidly spreading disease on the mental health of health workers. It is important that we support each other and recognise that every one is working outside of their comfort zone. Ensure rest and respite between shifts, eat sufficiently and stay in regular contact with friends, family and colleagues.",
            "cite_spans": [],
            "section": "Staff wellbeing",
            "ref_spans": []
        },
        {
            "text": "At some point soon, orthopaedic surgeons may have to step outside the comfort zone of trauma and orthopaedics and treat and triage any patient entering A&E. The Royal College of Surgeons has outlined this in its \u201cGuidance for surgeons\u201d and has set out 5 key phases:Triage and deliver healthcare and protect the workforceMaintain emergency surgery capabilitiesProtect and preserve the workforceFulfill alternate surgical rolesFulfill alternate non-surgical roles\n",
            "cite_spans": [],
            "section": "Treating COVID-19 suspected patients",
            "ref_spans": []
        },
        {
            "text": "It is therefore important that we:Understand the basics of COVID-19Recognise when to escalate to respiratory medics or ICUAre able to treat acute or emergent medical conditions as needed\n",
            "cite_spans": [],
            "section": "Treating COVID-19 suspected patients",
            "ref_spans": []
        },
        {
            "text": "Key terms",
            "cite_spans": [],
            "section": "Treating COVID-19 suspected patients",
            "ref_spans": []
        },
        {
            "text": "\nCOVID19 (Abbreviated from Corona Virus disease 2019) - Name of the disease caused with SARS-CoV-2)",
            "cite_spans": [],
            "section": "Treating COVID-19 suspected patients",
            "ref_spans": []
        },
        {
            "text": "\nSARS-CoV-2 (Abbreviated from Severe acute respiratory syndrome coronavirus 2)- Virus causing COVID-19.",
            "cite_spans": [],
            "section": "Treating COVID-19 suspected patients",
            "ref_spans": []
        },
        {
            "text": "This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.",
            "cite_spans": [],
            "section": "Treating COVID-19 suspected patients",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "TABREF0": {
            "text": "Table\u00a01: European nomenclature for filtering face pieces.\n",
            "type": "table"
        },
        "TABREF1": {
            "text": "Table\u00a02: US nomenclature as per Centre for Disease Control.\n",
            "type": "table"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "",
            "authors": [],
            "year": 2020,
            "venue": "PublicHealthEngland. Number of Coronavirus (COVID-19) Cases and Risk in the UK",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Tingbo",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis",
            "authors": [
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "Y.",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "X.",
                    "middle": [],
                    "last": "Gou",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Int J Infect Dis",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/j.ijid.2020.03.017"
                ]
            }
        },
        "BIBREF3": {
            "title": "Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?",
            "authors": [
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Fang",
                    "suffix": ""
                },
                {
                    "first": "G.",
                    "middle": [],
                    "last": "Karakiulakis",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Roth",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet Respir Med",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/S2213-2600(20)30116-8"
                ]
            }
        },
        "BIBREF4": {
            "title": "",
            "authors": [
                {
                    "first": "V.",
                    "middle": [],
                    "last": "Jain",
                    "suffix": ""
                },
                {
                    "first": "J.-M.",
                    "middle": [],
                    "last": "Yuan",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "Covid-19: a puzzle with many missing pieces",
            "authors": [
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Vetter",
                    "suffix": ""
                },
                {
                    "first": "I.",
                    "middle": [],
                    "last": "Eckerle",
                    "suffix": ""
                },
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Kaiser",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "BMJ",
            "volume": "368",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury",
            "authors": [
                {
                    "first": "C.D.",
                    "middle": [],
                    "last": "Russell",
                    "suffix": ""
                },
                {
                    "first": "J.E.",
                    "middle": [],
                    "last": "Millar",
                    "suffix": ""
                },
                {
                    "first": "J.K.",
                    "middle": [],
                    "last": "Baillie",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet",
            "volume": "395",
            "issn": "",
            "pages": "473-475",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF7": {
            "title": "Joint corticosteroid injection associated with increased influenza risk",
            "authors": [
                {
                    "first": "T.T.",
                    "middle": [],
                    "last": "Sytsma",
                    "suffix": ""
                },
                {
                    "first": "L.K.",
                    "middle": [],
                    "last": "Greenlund",
                    "suffix": ""
                },
                {
                    "first": "L.S.",
                    "middle": [],
                    "last": "Greenlund",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Mayo Clin Proc Innov Qual Outcomes",
            "volume": "2",
            "issn": "",
            "pages": "194-198",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF8": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF9": {
            "title": "",
            "authors": [
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Day",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF10": {
            "title": "Virtual fracture clinic delivers British Orthopaedic Association compliance",
            "authors": [
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Holgate",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Kirmani",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Anand",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Ann R Coll Surg Engl",
            "volume": "99",
            "issn": "",
            "pages": "51-54",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF11": {
            "title": "N95 vs FFP3 & FFP2 masks - what\u2019s the difference?",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "J D",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF12": {
            "title": "Fracture clinic redesign reduces the cost of outpatient orthopaedic trauma care",
            "authors": [
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Jenkins",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Morton",
                    "suffix": ""
                },
                {
                    "first": "G.",
                    "middle": [],
                    "last": "Anderson",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Van Der Meer",
                    "suffix": ""
                },
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Rymaszewski",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Bone Joint Res.",
            "volume": "5",
            "issn": "",
            "pages": "33-36",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF13": {
            "title": "The clinical and cost effectiveness of a virtual fracture clinic service: an interrupted time series analysis and before-and-after comparison",
            "authors": [
                {
                    "first": "A.",
                    "middle": [],
                    "last": "McKirdy",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Imbuldeniya",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Bone Joint Res.",
            "volume": "6",
            "issn": "",
            "pages": "259-269",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF14": {
            "title": "",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "RCS",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF15": {
            "title": "Management of patients with urgent orthopaedic conditions and trauma during the coronavirus pandemic2020.",
            "authors": [],
            "year": 2020,
            "venue": "BOAST Guidelines",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF16": {
            "title": "",
            "authors": [],
            "year": 2020,
            "venue": "N95 Respirators and Surgical Masks (Face Masks)",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF17": {
            "title": "A\u00a0novel coronavirus from patients with pneumonia in China, 2019",
            "authors": [
                {
                    "first": "N.",
                    "middle": [],
                    "last": "Zhu",
                    "suffix": ""
                },
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "W.",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "N\u00a0Engl J Med",
            "volume": "382",
            "issn": "",
            "pages": "727-733",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF18": {
            "title": "Does that face mask really protect you?",
            "authors": [
                {
                    "first": "L.E.",
                    "middle": [],
                    "last": "Bowen",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Appl Biosaf",
            "volume": "15",
            "issn": "",
            "pages": "67-71",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF19": {
            "title": "Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1",
            "authors": [
                {
                    "first": "N.",
                    "middle": [],
                    "last": "van Doremalen",
                    "suffix": ""
                },
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Bushmaker",
                    "suffix": ""
                },
                {
                    "first": "D.H.",
                    "middle": [],
                    "last": "Morris",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "N\u00a0Engl J Med",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1101/2020.03.09.20033217"
                ]
            }
        },
        "BIBREF20": {
            "title": "",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "ImperialCollegeLondon",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF21": {
            "title": "Effectiveness of N95 respirators versus surgical masks in protecting health care workers from acute respiratory infection: a systematic review and meta-analysis",
            "authors": [
                {
                    "first": "J.D.",
                    "middle": [],
                    "last": "Smith",
                    "suffix": ""
                },
                {
                    "first": "C.C.",
                    "middle": [],
                    "last": "MacDougall",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Johnstone",
                    "suffix": ""
                },
                {
                    "first": "R.A.",
                    "middle": [],
                    "last": "Copes",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Schwartz",
                    "suffix": ""
                },
                {
                    "first": "G.E.",
                    "middle": [],
                    "last": "Garber",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "CMAJ (Can Med Assoc J)",
            "volume": "188",
            "issn": "",
            "pages": "567-574",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF22": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        }
    }
}